{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:02:57Z","timestamp":1788447777267,"version":"build-2803163510"},"reference-count":45,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Res Protoc"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Stimulant use disorders (StimUDs), including cocaine and methamphetamine use disorders, remain a major public health concern in the United States with no US Food and Drug Administration (FDA)\u2013approved pharmacological treatments. The early recovery period following stimulant use is marked by sleep disturbances, heightened stress reactivity, and dysregulated reward processing, contributing to high rates of resumption of use. Evidence from animal and human studies supports the orexin neuropeptide system as a promising therapeutic target for minimizing these disruptive mechanisms. Suvorexant, an FDA-approved dual orexin receptor antagonist for insomnia, has previously been shown to improve sleep, reduce stress, and attenuate craving in the first-in-human study with non\u2013treatment-seeking individuals with cocaine use disorder.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n The primary objective of this randomized open-label clinical trial is to evaluate the effects of suvorexant on sleep, stress, reward processing, and craving during early abstinence in treatment-seeking individuals with StimUD. This proof-of-concept trial represents the first mechanistic evaluation of suvorexant in a residential sample of individuals with StimUD.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n A total of 40 participants, recruited from a residential treatment facility, will be randomized (1:1) to either 7 days of nightly suvorexant (10 mg) or treatment as usual. Participants\u2019 sleep will be monitored using an activity tracker watch, and they will complete a sleep diary each night to confirm bedtimes and wake-up times. Participants in the suvorexant group will receive the study medication for 7 nights. On premedication and postmedication study days, participants will be transported to the Center for Neurobehavioral Research on Addiction to complete the study sessions. At both study sessions, participants will complete self-report and safety measures (safety measures for the suvorexant group only) followed by administration of a stress reactivity test and an electroencephalographic assessment.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n The study was funded in January 2025 and is currently ongoing. We began enrollment of the first participant prior to funding in July 2024. At the time of manuscript submission (September 2025), a total of 8 participants had been enrolled in the study toward the planned enrollment of 40 participants. This study is expected to conclude in January 2027.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Findings from this study will provide initial evidence for the mechanisms involved in suvorexant for StimUD, with the long-term goal of repurposing orexin-based therapy to regulate neurobehavioral mechanisms and inform future medication development for StimUD.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/83842","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T17:51:21Z","timestamp":1775670681000},"page":"e83842-e83842","source":"Crossref","is-referenced-by-count":1,"title":["The Effects of Orexin Receptor Antagonism During Early Withdrawal in Stimulant Use Disorder: Protocol for a Proof-of-Concept Study"],"prefix":"10.2196","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0910-3095","authenticated-orcid":false,"given":"Heather","family":"Webber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0136-1928","authenticated-orcid":false,"given":"Nikky","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1886-7330","authenticated-orcid":false,"given":"Rita","family":"Blake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0306-1069","authenticated-orcid":false,"given":"Sarah","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2334-575X","authenticated-orcid":false,"given":"Trevor","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1846-3128","authenticated-orcid":false,"given":"Bill","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2822-3754","authenticated-orcid":false,"given":"Robert","family":"Suchting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2320-8977","authenticated-orcid":false,"given":"Jin","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8234-8235","authenticated-orcid":false,"given":"Jessica","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9140-5799","authenticated-orcid":false,"given":"Michael","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3561-4614","authenticated-orcid":false,"given":"Joy","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3447-6539","authenticated-orcid":false,"given":"Scott","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"issue":"1","key":"R1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41386-019-0465-x","article-title":"Drugs, sleep, and the addicted brain","volume":"45","author":"Valentino","journal-title":"Neuropsychopharmacology"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2021.787595","article-title":"Understanding the role of orexin neuropeptides in drug addiction: preclinical studies and translational value","volume":"15","author":"Matzeu","journal-title":"Front Behav Neurosci"},{"issue":"4","key":"R3","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.psc.2015.07.008","article-title":"Sleep disturbance in substance use disorders","volume":"38","author":"Roehrs","journal-title":"Psychiatr Clin North Am"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2019.146359","article-title":"Preliminary examination of the orexin system on relapse-related factors in cocaine use disorder","volume":"1731","author":"Suchting","journal-title":"Brain Res"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2011.05.052","article-title":"The default mode network and EEG \u03b1 oscillations: an independent component analysis","volume":"1402","author":"Knyazev","journal-title":"Brain Res"},{"issue":"4","key":"R6","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/psyp.12370","article-title":"The reward positivity: from basic research on reward to a biomarker for depression","volume":"52","author":"Proudfit","journal-title":"Psychophysiology"},{"issue":"2","key":"R7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3109\/00952990.2010.543998","article-title":"Characterizing methamphetamine withdrawal in recently abstinent methamphetamine users: a pilot field study","volume":"37","author":"Mancino","journal-title":"Am J Drug Alcohol Abuse"},{"key":"R8","unstructured":"First MB Williams JB Karg RS Spitzer RL . Structured Clinical Interview for DSM-5 Disorders - Research Version. American Psychiatric Association; 2015."},{"key":"R9","unstructured":"Snow G . blockrand: randomization for block randomized clinical trials. The Comprehensive R Archive Network. 2020. URL: https:\/\/cran.r-project.org\/web\/packages\/blockrand\/blockrand.pdf [Accessed 17-03-2026]"},{"issue":"1","key":"R10","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1080\/10550887.2024.2434298","article-title":"Preliminary examination of orexin receptor antagonism with suvorexant in individuals with methamphetamine use disorder: a case series study","volume":"44","author":"Webber","journal-title":"J Addict Dis"},{"issue":"4","key":"R11","first-page":"264","volume":"39","author":"Bennett","journal-title":"P T"},{"issue":"1","key":"R12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.sleh.2016.11.006","article-title":"National Sleep Foundation\u2019s sleep quality recommendations: first report","volume":"3","author":"Ohayon","journal-title":"Sleep Health"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-015-0409-x","article-title":"Sleeping problems in Chinese illicit drug dependent subjects","volume":"15","author":"Tang","journal-title":"BMC Psychiatry"},{"issue":"9","key":"R14","first-page":"38","volume":"6","author":"Mahfoud","journal-title":"Psychiatry (Edgmont)"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.4137\/SART.S10385","article-title":"Are you sleeping? Pilot comparison of self-reported and objective measures of sleep quality and duration in an inpatient alcoholism treatment program","volume":"6","author":"Brooks","journal-title":"Subst Abuse"},{"issue":"4","key":"R16","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/s1389-9457(00)00065-4","article-title":"Validation of the Insomnia Severity Index as an outcome measure for insomnia research","volume":"2","author":"Bastien","journal-title":"Sleep Med"},{"issue":"1","key":"R17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1080\/15402002.2012.636266","article-title":"Development of short forms from the PROMIS\u2122 sleep disturbance and Sleep-Related Impairment item banks","volume":"10","author":"Yu","journal-title":"Behav Sleep Med"},{"issue":"2","key":"R18","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1037\/1040-3590.10.2.176","article-title":"Psychometric properties of the 42-item and 21-item versions of the Depression Anxiety Stress Scales in clinical groups and a community sample","volume":"10","author":"Antony","journal-title":"Psychol Assess"},{"issue":"2","key":"R19","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1080\/10550887.2015.1116354","article-title":"Attentional bias in adults with cannabis use disorders","volume":"35","author":"Vujanovic","journal-title":"J Addict Dis"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2014.11.020","article-title":"On the invariance of the Stimulant Craving Questionnaire (STCQ) across cocaine and methamphetamine users","volume":"42","author":"Northrup","journal-title":"Addict Behav"},{"issue":"2","key":"R21","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/adb.12592","article-title":"Validation of a behavioral economic purchase task for assessing drug abuse liability","volume":"24","author":"MacKillop","journal-title":"Addict Biol"},{"issue":"4","key":"R22","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1037\/pha0000622","article-title":"Assessing cocaine motivational value: comparison of brain reactivity bias toward cocaine cues and cocaine demand","volume":"31","author":"Webber","journal-title":"Exp Clin Psychopharmacol"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108883","article-title":"Decreased cocaine demand following contingency management treatment","volume":"226","author":"Yoon","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"R24","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1037\/adb0000475","article-title":"Baseline cocaine demand predicts contingency management treatment outcomes for cocaine-use disorder","volume":"34","author":"Yoon","journal-title":"Psychol Addict Behav"},{"issue":"4","key":"R25","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1037\/pha0000367","article-title":"Assessment of demand for methamphetamine and cigarettes among individuals with methamphetamine use disorder","volume":"29","author":"Yoon","journal-title":"Exp Clin Psychopharmacol"},{"issue":"12","key":"R26","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults","volume":"168","author":"Posner","journal-title":"Am J Psychiatry"},{"key":"R27","doi-asserted-by":"crossref","unstructured":"Beck AT Steer RA Brown GK . Beck Depression Inventory. 2nd ed. Guilford Press; 1996.","DOI":"10.1037\/t00742-000"},{"issue":"3","key":"R28","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-s","article-title":"The fifth edition of the Addiction Severity Index","volume":"9","author":"McLellan","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"R29","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.neuroimage.2009.01.001","article-title":"BOLD correlates of EEG alpha phase-locking and the fMRI default mode network","volume":"45","author":"Jann","journal-title":"Neuroimage"},{"issue":"1","key":"R30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/00045391-199701000-00008","article-title":"The cold pressor test: pharmacological and therapeutic aspects","volume":"4","author":"Velasco","journal-title":"Am J Ther"},{"issue":"6","key":"R31","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/hup.778","article-title":"Stress reactivity: biological and subjective responses to the cold pressor and Trier Social stressors","volume":"21","author":"McRae","journal-title":"Hum Psychopharmacol"},{"issue":"3","key":"R32","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-8986.1975.tb01289.x","article-title":"The cold pressor test and autonomic function: a review and integration","volume":"12","author":"Lovallo","journal-title":"Psychophysiology"},{"issue":"3","key":"R33","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.appet.2012.08.025","article-title":"Plasma cortisol levels in response to a cold pressor test did not predict appetite or ad libitum test meal intake in obese women","volume":"59","author":"Geliebter","journal-title":"Appetite"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2015.07.006","article-title":"Anti-saccade error rates as a measure of attentional bias in cocaine dependent subjects","volume":"292","author":"Dias","journal-title":"Behav Brain Res"},{"key":"R35","unstructured":"R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing. 2024. URL: https:\/\/www.R-project.org\/ [Accessed 17-03-2026]"},{"key":"R36","unstructured":"Bates D M\u00e4chler M Bolker B Walker S . Fitting linear mixed-effects models using lme4. arXiv. Preprint posted online on Jun 23, 2014. [doi: 10.48550\/arXiv.1406.5823]"},{"key":"R37","unstructured":"Stan Development Team. RStan: the R interface to Stan. The Comprehensive R Archive Network. 2025. URL: https:\/\/cran.r-project.org\/web\/packages\/rstan\/vignettes\/rstan.html [Accessed 17-03-2026]"},{"issue":"1","key":"R38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v080.i01","article-title":"brms: an R package for Bayesian multilevel models using Stan","volume":"80","author":"B\u00fcrkner","journal-title":"J Stat Softw"},{"issue":"9209","key":"R39","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/S0140-6736(00)02039-0","article-title":"Subgroup analysis and other (mis)uses of baseline data in clinical trials","volume":"355","author":"Assmann","journal-title":"Lancet"},{"issue":"19","key":"R40","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1002\/sim.1296","article-title":"Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems","volume":"21","author":"Pocock","journal-title":"Stat Med"},{"key":"R41","unstructured":"McElreath R . Statistical Rethinking: A Bayesian Course with Examples in R and Stan. CRC Press; 2016."},{"key":"R42","doi-asserted-by":"crossref","unstructured":"Gelman A Carlin JB Stern HS Dunson DB Vehtari A Rubin DB . Bayesian Data Analysis. 3rd ed. CRC Press; 2013.","DOI":"10.1201\/b16018"},{"key":"R43","doi-asserted-by":"crossref","unstructured":"Jeffreys H . The Theory of Probability. 3rd ed. Oxford University Press; 1998. ISBN: 9780198503682","DOI":"10.1093\/oso\/9780198503682.001.0001"},{"key":"R44","doi-asserted-by":"crossref","unstructured":"Lee MD Wagenmakers EJ . Bayesian Cognitive Modeling: A Practical Course. Cambridge University Press; 2013. ISBN: 9781107018457","DOI":"10.1017\/CBO9781139087759"},{"key":"R45","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2022.173466","article-title":"Suvorexant maintenance enhances the reinforcing but not subjective and physiological effects of intravenous cocaine in humans","volume":"220","author":"Stoops","journal-title":"Pharmacol Biochem Behav"}],"container-title":["JMIR Research Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e83842","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:18:01Z","timestamp":1782843481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e83842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":45,"URL":"https:\/\/doi.org\/10.2196\/83842","relation":{},"ISSN":["1929-0748"],"issn-type":[{"value":"1929-0748","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,8]]},"article-number":"v15i1e83842"}}